Our work demonstrated that it reduces in a dose- and in a time-dependent manner the expression of Gli1, NR0B1, FOXM1 and VEGFA, some of the EWS-Fli1 target-genes considered as determining factors in the carcinogenesis of Ewing Sarcoma [19, 55–57]. Here, VEGFA is linked to Ewing sarcoma.